NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 3, 2025. S&P MidCap 400 constituent SouthState Corp. (NYSE: SSB) is...
Read More Details
Finally We wish PressBee provided you with enough information of ( Acadia Pharmaceuticals Set to Join S&P SmallCap 600 )
Also on site :
- ‘This is about more than burgers and fries’: Boycott of McDonald’s to begin this week
- Trump announces Iran and Israel have agreed to a “Complete and Total CEASEFIRE"
- Royals Option Kyle Wright